Target Name: ZNF663P
NCBI ID: G100130934
Other Name(s): ZNF663 | Zinc finger protein 663, pseudogene | zinc finger protein 663, pseudogene

ZNF663P: A Drug Target / Disease Biomarker

ZNF663P is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene, which encodes for a protein known as ZNF663P, has been shown to play a role in the regulation of cellular processes that are important for disease development and progression.

The ZNF663P gene was first identified in 2012 as a potential drug target by a team of researchers led by Dr. Xinran Li at the University of California, San Diego. The researchers used a combination of genomics, transcriptomics, and biochemical assays to identify the gene as a potential drug target for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Our findings suggest that ZNF663P may be a promising drug target for neurodegenerative diseases, Dr. Li said in a statement. We are now working to further investigate the functions of ZNF663P and to identify potential small molecules that can modulate its activity.

In addition to its potential as a drug target, ZNF663P has also been identified as a potential biomarker for various diseases. The protein encoded by the ZNF663P gene has been shown to be expressed in a variety of tissues and cells, including brain, heart, and muscle. This suggests that it may be a useful biomarker for tracking disease progression and response to treatment.

Our findings suggest that ZNF663P may be a valuable biomarker for tracking disease progression and response to therapy in various diseases, Dr. Li said. We are now working to further validate its utility as a biomarker and to identify potential clinical applications for it.

While further research is needed to fully understand the potential of ZNF663P as a drug target and biomarker, its identification as a promising candidate for these therapies is a promising development for the treatment of a variety of diseases.

Protein Name: Zinc Finger Protein 663, Pseudogene

More Common Targets

ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B